Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

SRP54b Activators

The chemical class known as SRP54B Activators encompasses a range of compounds that can influence the function of the SRP54B protein, which plays a crucial role in the co-translational targeting pathway and is integral to protein synthesis and targeting to the endoplasmic reticulum (ER). While direct chemical activators for SRP54B are not specifically documented, this class refers to chemicals that can modulate the broader cellular processes and pathways in which SRP54B is involved. These activators are characterized by their ability to affect translation, ER targeting, and GTPase activity, which are all essential functions related to the activity of SRP54B. The modulating effects of these chemicals can lead to changes in the protein synthesis machinery, ER-associated protein folding, and post-translational modifications, which in turn can alter the demand and functionality of SRP54B within the cell.

The activation of SRP54B through these chemicals is a reflection of the intricate network of cellular mechanisms and the delicate balance of protein homeostasis within the cell. By influencing the upstream processes of protein translation or the downstream effects of protein trafficking, these compounds can indirectly affect the operational dynamics of SRP54B. For example, certain compounds can lead to the accumulation of nascent polypeptides that necessitate SRP54B's involvement, while others can interact with the GTPase activity that is central to SRP54B's function in the SRP pathway. The diverse chemical nature of these activators underscores the complexity of targeting such a pivotal component within the cellular machinery. The study of this chemical class is focused on understanding how the modulation of related cellular processes can in turn regulate the activity of SRP54B, thereby offering insights into the fundamental aspects of protein biogenesis and intracellular transport.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(15)

Puromycin causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA, which could possibly activate SRP54B by interrupting the translation process that SRP54B is involved in.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits eukaryotic protein synthesis by interfering with translational elongation. This could possibly activate SRP54B by affecting the pool of nascent polypeptides available for SRP54B to bind.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which is a central regulator of cell growth and protein synthesis. This could possibly activate SRP54B's role in targeting nascent polypeptides to the ER.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts ER to Golgi transport, which could possibly activate SRP54B by leading to an accumulation of proteins in the ER.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin blocks N-linked glycosylation, which could possibly activate SRP54B by leading to ER stress and altering the targeting of nascent polypeptides to the ER.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin interferes with peptide chain elongation during protein synthesis. It could possibly activate SRP54B by influencing the overall protein synthesis process that SRP54B is part of.

Fusidic acid

6990-06-3sc-215065
1 g
$292.00
(0)

Fusidic acid prevents the turnover of elongation factor G (EF-G) from the ribosome, which could possibly activate SRP54B by impacting its role in recognizing nascent polypeptides.